World Orphan Drug Congress USA 2016
community download

SCENESSE®: Commercialization of a First-In-Class NCE

Nicoletta Muner of Clinuvel Pharmaceuticals Ltd.   joined us for World Orphan Drug Congress USA 2015 to present about ' SCENESSE®    :Commercialization of a First-In-Class NCE'
 
Download her presentation now to understand more about:
  • Scenesse Clincial Program
  • Erythropoietic Protoporphyria (EPP)
  • EPP Clinical Development and Expanded Access
  • EMA Evaluation (Centralised Procedur)
...and much more!  
 
Get your copy here! 
 
To find out more about  SCENESSE®   , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC. 

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (645Kb in size)